Health10 hours ago
CERo Therapeutics Denied Nasdaq Listing, Eyes OTC Markets
CERo Therapeutics, a company specializing in cellular immunotherapy, has received a determination letter from the Nasdaq Hearings Panel. This letter confirms the denial of the company’s...